A clinical trial has shown some positive findings for a new Alzheimer’s drug called Lecanemab.
Did you know with a Digital Subscription to Hartlepool Mail, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more.
